Roche, M., Salimi, H., Duncan, R., Wilkinson, B., Chikere, K., Moore, M., . . . Gorry, P. (2013). A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations.
Chicago Style (17th ed.) CitationRoche, M., et al. A Common Mechanism of Clinical HIV-1 Resistance to the CCR5 Antagonist Maraviroc Despite Divergent Resistance Levels and Lack of Common Gp120 Resistance Mutations. 2013.
MLA (9th ed.) CitationRoche, M., et al. A Common Mechanism of Clinical HIV-1 Resistance to the CCR5 Antagonist Maraviroc Despite Divergent Resistance Levels and Lack of Common Gp120 Resistance Mutations. 2013.
Warning: These citations may not always be 100% accurate.